Trials / Completed
CompletedNCT00740025
Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)
A Prospective Randomized Study of QD vs BID Dosing in ART
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Virginia Center for Reproductive Medicine · Academic / Other
- Sex
- Female
- Age
- 21 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.
Detailed description
Using once daily or bid dosing of gonadotropins in ART has been arbitrary with no studies showing whether splitting the medication dose improves ART parameters. This study was undertaken to provide an answer to this important question.
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2008-08-22
- Last updated
- 2010-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00740025. Inclusion in this directory is not an endorsement.